Potassium Canrenoate in Brain-dead Organ Donors: Randomized Controlled Clinical Trial
NCT04714710
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Brain-dead Organ Donors
Interventions
DRUG:
IV Potassium Canrenoate
DRUG:
IV Sodium Chloride 0.9 %
Sponsor
Pr. Nicolas GIRERD